SCHEMBL47319

SCHEMBL47319

CC(C)(C)OC(=O)N1CCC(O)CC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.60
RECQL P46063 1/20 0.57
EPHX1 P07099 1/20 0.57
USP2 O75604 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
CHRM2 P08172 1/20 0.53
CHRM1 P11229 1/20 0.53
CHRM3 P20309 1/20 0.53
GPR119 Q8TDV5 6/20 0.53
MAPT P10636 2/20 0.51
KDM4E B2RXH2 1/20 0.51
THRB P10828 1/20 0.51
PTPN2 P17706 1/20 0.51
PTPN1 P18031 1/20 0.51
PTPN6 P29350 1/20 0.51
ALDH1A1 P00352 2/20 0.49
NPC1 O15118 1/20 0.48
MAPK1 P28482 1/20 0.48
HTT P42858 1/20 0.48
RAB9A P51151 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethane SCHEMBL897978 1.00 HPGD (0.60) HPGDRECQLEPHX1USP2SMN1; SMN2
SCHEMBL1148424 0.98 HPGD (0.58) HPGDRECQLEPHX1USP2SMN1; SMN2
Hydrochloric Acid SCHEMBL6803311 0.98 HPGD (0.58) HPGDRECQLEPHX1USP2SMN1; SMN2
Methane SCHEMBL28191135 0.98 HPGD (0.58) HPGDRECQLEPHX1USP2SMN1; SMN2
SCHEMBL27638887 0.94 GPR119 (0.56) HPGDRECQLEPHX1USP2SMN1; SMN2
SCHEMBL1096914 0.93 HPGD (0.62) HPGDRECQLEPHX1USP2SMN1; SMN2
SCHEMBL28577405 0.93 HPGD (0.54) HPGDRECQLEPHX1USP2SMN1; SMN2
SCHEMBL2217466 0.93 HPGD (0.54) HPGDRECQLEPHX1USP2SMN1; SMN2
SCHEMBL15107851 0.93 HPGD (0.62) HPGDRECQLEPHX1USP2SMN1; SMN2
SCHEMBL13779779 0.93 HPGD (0.62) HPGDRECQLEPHX1USP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 10568 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122079865-A Preparation method and application of key intermediate of Revelinaxin 2026-05-26 CN claimed
US-20250314970-A1 OVERCOAT COMPOSITION AND PATTERNING METHODS TOKYO ELECTRON LTD (JP) 2025-10-09 US claimed
US-20250244664-A1 PHOTORESIST COMPOSITIONS AND PATTERNING METHODS U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2025-07-31 US claimed
US-20250102910-A1 PHOTORESIST COMPOSITION AND METALLIZATION METHOD U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2025-03-27 US claimed
CN-119668029-A Stable chemically amplified positive photoresist and preparation and use methods thereof 徐州博康信息化学品有限公司 2025-03-21 CN claimed
CN-119322427-A Photoresist composition and metallization method 杜邦电子材料国际有限责任公司 2025-01-17 CN claimed
CN-119291995-A Thick film KrF photoresist composition and preparation and use methods thereof 徐州博康信息化学品有限公司 2025-01-10 CN claimed
CN-119285632-A Preparation method of capromorelin intermediate based on catalytic oxidation of yeast alcohol dehydrogenase 威海中腾医药科技有限公司 2025-01-10 CN claimed
CN-118688342-A Detection method of related substances of delamani starting material 沈阳双鼎制药有限公司 2024-09-24 CN claimed
US-20240231227-A1 OXATHIANIUM ION-CONTAINING SULFONIC ACID DERIVATIVE COMPOUND AS PHOTOACID GENERATORS IN RESIST APPLICATIONS HERAEUS EPURIO LLC 2024-07-11 US claimed
EP-1900733-A1 PROCESS FOR PRODUCTION OF 4(3H)-QUINAZOLINONE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-03-19 EP claimed
EP-1877401-A2 NOVEL COMPOUNDS USEFUL FOR BRADYKININ B1 RECEPTOR ANTAGONISM Elan Pharmaceuticals Inc. (US) 2008-01-16 EP claimed
CN-101100474-A Fluoroquinolone compound containing phosphate group, preparation method and application thereof SHANGHAI YANGFAN MEDICINE SCIE (CN) 2008-01-09 CN claimed
US-20070032475-A1 Novel compounds useful for bradykinin B1 receptor antagonism ELAN PHARMACEUTICALS, INC. 2007-02-08 US claimed
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed
WO-2006113140-A2 NOVEL COMPOUNDS USEFUL FOR BRADYKININ B1 RECEPTOR ANTAGONISM ELAN PHARMACEUTICALS, INC. (US) 2006-10-26 WO claimed
WO-2005003140-A1 4-OXO-4,7-DIHYDROTHIENO[2,3-B]PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2005-01-13 WO claimed
US-20050004161-A1 4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents AGOURON PHARMACEUTICALS, INC. 2005-01-06 US claimed
EP-1397364-A1 NOVEL PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS ELI LILLY AND COMPANY (US) 2004-03-17 EP claimed
WO-2002094833-A1 NOVEL PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS ELI LILLY AND COMPANY (US) 2002-11-28 WO claimed